Dan Scavilla
CEO Dan Scavilla, appointed in April 2022, will primarily execute the vision of Globus Medical's founder, David Paul, due to his lack of strategic direction and deep industry expertise.
Despite his strong financial acumen, Scavilla's authoritarian management style and poor strategic decision-making have raised concerns among colleagues, making him a weak choice for CEO.
Multiple sources voiced concerns about Scavilla's integrity and potential gender issues in the workplace, further questioning his suitability for the role.
By submitting this form, you are agreeing to ManagementTrack’s Privacy Policy. You can choose to opt out of marketing or advertising emails using the ‘unsubscibe’ link included in our emails.
The best
The best
The best
Our investigative journalists interview the top former colleagues of the CEOs you care about.
Our former buysider analysts summarize the key strengths & weaknesses, past successes & failures, and ability to drive value going forward.
You get access to the actual anonymized transcripts and insights.